Mednet Logo
HomeHematologyQuestion

What is the preferred approach for giving high dose methotrexate in double or triple hit lymphomas being treated with dA-EPOCH-R?

2
2 Answers
Mednet Member
Mednet Member
Medical Oncology · University of Maryland Cancer Center

I do not usually offer HD IV methotrexate for DHL without documented CNS disease. Instead, I use 4 cycles of IT methotrexate in addition to DA R-EPOCH (Blood 2017). For patients with documented CNS involvement, you can place an Ommaya reservoir for an intensive intrathecal therapy and I recommend us...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Medical Oncology · University of Alabama Birmingham

This is a great question. DHL have high risk of CNS involvement and primary prophylaxis is very important. Most of the lymphoma experts would prefer R-DA-EPOCH approach if the patient can tolerate an aggressive approach. In my practice, I prefer high dose methotraxate over intrathecal chemotherapy (...

Register or Sign In to see full answer

What is the preferred approach for giving high dose methotrexate in double or triple hit lymphomas being treated with dA-EPOCH-R? | Mednet